Aliri

Colorado Springs, United States Founded: 2009 • Age: 17 yrs
CRO focused on drugs discovery, method development, and validation services
Annual revenue - Latest available
Total funding $1.2M 2 rounds
Employees 22 Tracked headcount
Investors 3 Known backers
Products 4 Services tracked
Competitors 10 Brand Intelligence

About Aliri

Aliri is a company based in Colorado Springs (United States) founded in 2009. Aliri has raised $1.25 million across 2 funding rounds from investors including Siparex, European Union and Finovam Gestion. The company has 22 employees as of December 31, 2015. Aliri has completed 1 acquisition, including Pyxant. Aliri offers products and services including Bioanalytical Services, Spatial Services, Method Development, and Sample Analysis. Aliri operates in a competitive market with competitors including Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and Dotmatics, among others.

  • Headquarter Colorado Springs, United States
  • Employees 22 as on 31 Dec, 2015
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Aliri
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $1.25 M (USD)

    in 2 rounds

  • Latest Funding Round
    $337.01 K (USD), Grant

    Jan 01, 2021

  • Investors
    Siparex

    & 2 more

  • Employee Count
    22

    as on Dec 31, 2015

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Aliri

Aliri offers a comprehensive portfolio of products and services, including Bioanalytical Services, Spatial Services, Method Development, and Sample Analysis.

Product name locked
Category locked
Primary

Offers testing and method development for drug discovery programs.

Product name locked
Category locked
Locked

Provides imaging and analysis for drug exposure and efficacy studies.

Product name locked
Category locked
Locked

Develops and validates methods for sample analysis in pharmaceuticals.

Product name locked
Category locked
Locked

Conducts assays and analysis for toxicity and pharmacokinetic studies.

People of Aliri

Headcount 50-200
Employee Profiles 18
Employee Profiles
People
David Good
Senior Director Of Business Development
People
Alexandra Martin
Sr. Director, Business Development
People
Chris Hardcastle
Research Associate II
People
Diane Pollock
Manager, Sample Management And Archives

Unlock access to complete

Funding Insights of Aliri

Aliri has successfully raised a total of $1.25M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $337.01 thousand completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Aliri

Aliri has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Siparex, European Union and Finovam Gestion.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Finovam Gestion is engaged in investing in future technological leaders.
Locked Locked Locked
Private equity investments are focused on growth stage companies.
Locked Locked Locked
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Locked Locked Locked
Premium access

Investor details for Aliri

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Aliri

Aliri has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Pyxant.

Investments
Premium access

Investment portfolio details for Aliri

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
GLP bioanalytical services for drug development are provided by Pyxant.
Locked Locked 1984 Locked
Premium access

Complete acquisition details for Aliri

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Aliri

Premium access

Detailed financials for Aliri

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Aliri Comparisons

Aliri Primary company
Description
CRO focused on drugs discovery, method development, and vali...
Location
Colorado Springs, United States
Founded Year
2009
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
22
As of 2015
Premium access

Peer comparison for Aliri

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Aliri

Aliri operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and Dotmatics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Drug discovery and development services for small molecules are provided.
Locked Locked Locked
CDMO services for pharma, biotech, and specialty ingredients are provided.
Locked Locked Locked
Pharmaceutical products for treating multiple diseases are provided.
Locked Locked Locked
Generic drugs and clinical research services are provided globally.
Locked Locked Locked
AI powered scientific data management and workflow automation solutions
Locked Locked Locked
Laboratory testing, clinical trial research, and biopharma services are provided.
Premium access

Detailed competitors of Aliri

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Aliri

Premium access

Complete news archive for Aliri

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aliri

Aliri was founded in 2009 and raised its 1st funding round 5 years after it was founded.

Aliri is headquartered in Colorado Springs, United States. It is registered at Colorado Springs, Colorado, United States.

Aliri is a funded company, having raised a total of $1.25M across 2 funding rounds to date.

As of Dec 31, 2015, the latest employee count at Aliri is 22.

Aliri was founded in 2009 and is based in Colorado Springs, United States. Operations are centered on contract research organization services within the pharmaceutical sector. Drug discovery processes are supported, alongside method development and validation for analytical and bioanalytical needs. Expertise is applied to assist clients in advancing therapeutic candidates through preclinical stages, with a focus on regulatory compliance and quality standards.

Aliri's top competitors include Pharmaron, Pfizer and Lonza.

Aliri offers Bioanalytical Services, Spatial Services, Method Development, and Sample Analysis.

Aliri has made 1 acquisition, including Pyxant.

Aliri has 3 investors. Key investors include Siparex, European Union, and Finovam Gestion.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available